Provided By PR Newswire
Last update: Dec 27, 2024
NEW YORK, Dec. 27, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of XBiotech Inc. ("XBiotech" or the "Company") (NASDAQ: XBIT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read more at prnewswire.comNASDAQ:XBIT (12/11/2025, 8:13:11 PM)
2.55
-0.01 (-0.39%)
Find more stocks in the Stock Screener


